PLENARY PANEL DISCUSSIONS:
Moderator + Four Panelists

Welcome and Meeting Overview

KEYNOTE ADDRESS:  Federal Policy—A New Vision

KEYNOTE ADDRESS: Why JDRF is Investing in Stem Cell Research

How Stem Cell Research is Transforming Health Care—US and Globally

SCIENCE SESSIONS:
Moderator + Four Panelists

Human Embryonic Stem Cells vs. Induced Pluripotent Stem Cells

Stem Cells, Nanotechnology and Bioengineering

Stem Cells and Disease Modeling Presentations

Neural Stem Cell Presentations

Cardiac Presentations

Cancer Stem Cell Presentations

Mesenchymal and Hematopoietic Stem Cells Presentations

Opportunities for Federal Funding


BUSINESS SESSIONS:
Moderator + Four Panelists

Cells, Growth Factors, Scaffolds, Bioreactors: The Key Technologies in the ReGEN Industry to Reach the Market With Stem Cell-Based Therapeutics

Big Pharma , Big Biotech, Big Device and the ReGEN Industry

Regulatory and Reimbursement Strategies

Commercialization of Stem Cells and International Alliances, Partnerships and Acquisitions

Stem Cell Law- Advanced Intellectual Property Issues

Commercialization of SC and International Market Trends

Licensing, Technology Transfer and Partnering in the ReGEN Industry

Business Models for Successful Stem Cell Companies and Innovative Funding Mechanisms


DISEASE FOCUS SESSIONS:
Moderator + Scientist, Industry Leader, Clinician, Consumer & Foundation

Spinal Cord Injury and Multiple Sclerosis

Cancer

Cardiovascular  

Diabetes

Parkinson’s / ALS / Neurological Disorders


SOCIETY SESSIONS:
Moderator + Four Panelists

Ethics and Societal Issues

Case Study: Maryland’s Investment in Stem Cell Science

Regenerative Medicine for Wounded Soldiers and Civilians

Stem Cells and the Potential for National and Regional Economic Development

Stem Cell Action- A New Agenda for Advocates

Stem Cells in Clinical Treatments and Medical Tourism: What's Here and Now

Cord Blood and Cell Banking: Answers for Patients, Researchers, and Industry

Forecasting Tomorrow's Stem Cell Headlines